Acasti Pharma, Inc. (ACST) earnings
Quarterly and annual ACST reports and results, each read against the price at its own news timestamp. Back to the ACST overview →
8 measured ACST earnings events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q/A Grace Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-Q | — | — | |
| Form 10-Q Grace Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-Q | — | — | |
| Form 10-Q Grace Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | — | — | |
| Form 10-Q Acasti Pharma Inc. For: Jun 30 | SEC filing · Form 10-Q | -0.18% | -3.28% | |
| Form 10-K Acasti Pharma Inc. For: Mar 31 | SEC filing · Form 10-K | +3.95% | +4.76% | |
| Form 10-Q Acasti Pharma Inc. For: Dec 31 | SEC filing · Form 10-Q | +0.00% | +6.97% | |
| Acasti Announces Second Quarter 2024 Financial Results and Business Highlights | Press release | -1.40% | +0.47% | |
| Form 10-Q Acasti Pharma Inc. For: Sep 30 | SEC filing · Form 10-Q | -1.40% | +0.47% |
Keep exploring
More ACST: analyst actions → · SEC filings → · ACST overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Trevena, Inc. (TRVN) | 91 | 0.00% | 46% |
| CV SCIENCES INC (CVSI) | 90 | +0.59% | 53% |
| Microbix Biosystems Inc (MBX_TSE) | 89 | 0.00% | 32% |
| VIVOS INC (RDGL) | 88 | 0.00% | 43% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.